These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18831918)

  • 1. A quercetin containing supplement reduces niacin-induced flush in humans.
    Kalogeromitros D; Makris M; Chliva C; Aggelides X; Kempuraj D; Theoharides TC
    Int J Immunopathol Pharmacol; 2008; 21(3):509-14. PubMed ID: 18831918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonoid luteolin inhibits niacin-induced flush.
    Papaliodis D; Boucher W; Kempuraj D; Theoharides TC
    Br J Pharmacol; 2008 Apr; 153(7):1382-7. PubMed ID: 18223672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model.
    Papaliodis D; Boucher W; Kempuraj D; Michaelian M; Wolfberg A; House M; Theoharides TC
    J Pharmacol Exp Ther; 2008 Dec; 327(3):665-72. PubMed ID: 18784348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important considerations for treatment with dietary supplement versus prescription niacin products.
    Backes JM; Padley RJ; Moriarty PM
    Postgrad Med; 2011 Mar; 123(2):70-83. PubMed ID: 21474895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush.
    Meyers CD; Liu P; Kamanna VS; Kashyap ML
    Atherosclerosis; 2007 Jun; 192(2):253-8. PubMed ID: 16945375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    Morrow JD; Parsons WG; Roberts LJ
    Prostaglandins; 1989 Aug; 38(2):263-74. PubMed ID: 2475889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans.
    Morrow JD; Awad JA; Oates JA; Roberts LJ
    J Invest Dermatol; 1992 May; 98(5):812-5. PubMed ID: 1373750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Flush-free niacin": dietary supplement may be "benefit-free".
    Norris RB
    Prev Cardiol; 2006; 9(1):64-5. PubMed ID: 16407706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
    J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
    Bays HE; Ballantyne C
    Curr Opin Lipidol; 2009 Dec; 20(6):467-76. PubMed ID: 19779335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of aspirin on niacin-induced cutaneous reactions.
    Whelan AM; Price SO; Fowler SF; Hainer BL
    J Fam Pract; 1992 Feb; 34(2):165-8. PubMed ID: 1737967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
    Paolini JF; Mitchel YB; Reyes R; Kher U; Lai E; Watson DJ; Norquist JM; Meehan AG; Bays HE; Davidson M; Ballantyne CM
    Am J Cardiol; 2008 Mar; 101(5):625-30. PubMed ID: 18308010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders.
    Taliou A; Zintzaras E; Lykouras L; Francis K
    Clin Ther; 2013 May; 35(5):592-602. PubMed ID: 23688534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoid no-flush niacin in favor of the prescription version. Follow certain steps to reduce the flushing effects of prescription niacin.
    Heart Advis; 2010 Nov; 13(11):5. PubMed ID: 22834056
    [No Abstract]   [Full Text] [Related]  

  • 15. Niacin, an old drug with new perspectives for the management of dyslipidaemia.
    Benhalima K; Muls E
    Acta Clin Belg; 2010; 65(1):23-8. PubMed ID: 20373594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing.
    Parson HK; Harati H; Cooper D; Vinik AI
    J Diabetes; 2013 Mar; 5(1):59-67. PubMed ID: 22727040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On call. In your January 2007 article on cholesterol, you said that no-flush niacin does not lower cholesterol levels. But my problem is low HDL cholesterol. Will no-flush niacin help my HDL even if it won't lower my LDL cholesterol?
    Simon HB
    Harv Mens Health Watch; 2007 Jun; 11(11):7-8. PubMed ID: 17644843
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia.
    Fazio S; Guyton JR; Polis AB; Adewale AJ; Tomassini JE; Ryan NW; Tershakovec AM
    Am J Cardiol; 2010 Feb; 105(4):487-94. PubMed ID: 20152243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When taking niacin to help lower my LDL and raise my HDL, I have experienced a hot and itchy "flushing" sensation, which I understand is very common. Are there any "no flush" niacin products on the market?
    Heart Advis; 2007 Nov; 10(11):8. PubMed ID: 18271102
    [No Abstract]   [Full Text] [Related]  

  • 20. Niacin use and cutaneous flushing: mechanisms and strategies for prevention.
    Davidson MH
    Am J Cardiol; 2008 Apr; 101(8A):14B-19B. PubMed ID: 18375236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.